Bipolar Disorders
Conditions
Keywords
bipolar disorders, everyday setting, treatment adherence, global
Brief summary
This study is to provide reliable information on the management of bipolar disorders in real every day, clinical practice, to determine the clinical outcomes of such management and use of resources in relation to the disease, and to establish the factors associated with different management patterns and clinical outcomes.
Interventions
None listed
Sponsors
AstraZeneca
Study design
Observational model
COHORT
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of Bipolar Disorder I or II (DSM-IV TR) in any phase of the disorder * Patients who had at least one mood event (depression, mania, hypomania or mixed) according to DSM-IV TR definition during the 12 months prior to the beginning of the study
Exclusion criteria
* Patients who had the index mood event during the 3 months before the beginning of the study (Time 0).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Demographic variables | Once during study |
| 1-year prevalence for each disease phase | everytime the patient attends the consult |
Secondary
| Measure | Time frame |
|---|---|
| treatments prescribed, FAST | everytime the patient attends the consult |
| treatments prescribed, DAI-10 | everytime the patient attends the consult |
| Use of resources | everytime the patient attends the consult |
| treatments prescribed, BAS | Once during the prospective part (only if patient attends with a caregiver) |
| treatments prescribed, MPR | everytime the patient attends the consult |
| treatments prescribed, EQ5D | everytime the patient attends the consult |
Countries
Austria, Belgium, Brazil, France, Germany, Portugal, Romania, Turkey (Türkiye), Ukraine, Venezuela
Outcome results
None listed